Loading...

Evolva Holding S.A.

EVE.SWSIX
Healthcare
Biotechnology
CHF1.05
CHF-0.04(-3.67%)

Evolva Holding S.A. (EVE.SW) Company Profile & Overview

Explore Evolva Holding S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Evolva Holding S.A. (EVE.SW) Company Profile & Overview

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

SectorHealthcare
IndustryBiotechnology
CEOGerhard Lobmaier

Contact Information

41 61 485 2000
Duggingerstrasse 23, Reinach, 4153

Company Facts

49 Employees
IPO DateMay 3, 2005
CountryCH
Actively Trading

Frequently Asked Questions

;